Exane Asset Management’s Elevance Health ELV Stock Holding History

Exane Asset Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-191	Closed	-$42K	–	139
2018 Q1	$42K	Buy	+191	New	+$44.9K	0.01%	112

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Exane Asset Management's ELV Position: Q2 2018 in Review

Exane Asset Management sold out of Elevance Health (ELV) in Q2 2018, closing a stake of 191 shares — an estimated $42K sold.

Exane Asset Management first reported a position in ELV in Q1 2018 and held it in 1 quarter. The position peaked at $42K in Q1 2018. 934 funds tracked by Wall St. Rank hold ELV as of Q2 2018.

Exane Asset Management reported no remaining Elevance Health position as of Q2 2018 after selling out during the quarter.
Exane Asset Management sold 191 Elevance Health shares in Q2 2018, an estimated $42K.
Exane Asset Management first reported a position in Elevance Health in Q1 2018 and held it in 1 quarter.
Exane Asset Management's Elevance Health position peaked at $42K in Q1 2018.
934 funds tracked by Wall St. Rank held Elevance Health as of Q2 2018.

Based on Exane Asset Management's 13F filing for Q2 2018, filed 6 Sep 2018.